DK1934388T3 - Fremgangsmåde til lægemiddeludvikling - Google Patents
Fremgangsmåde til lægemiddeludviklingInfo
- Publication number
- DK1934388T3 DK1934388T3 DK06790302.1T DK06790302T DK1934388T3 DK 1934388 T3 DK1934388 T3 DK 1934388T3 DK 06790302 T DK06790302 T DK 06790302T DK 1934388 T3 DK1934388 T3 DK 1934388T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug development
- drug
- development
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005905465A AU2005905465A0 (en) | 2005-10-04 | Method of Drug Design | |
PCT/AU2006/001431 WO2007038829A1 (en) | 2005-10-04 | 2006-10-03 | Method of drug design |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1934388T3 true DK1934388T3 (da) | 2013-02-25 |
Family
ID=37905903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06790302.1T DK1934388T3 (da) | 2005-10-04 | 2006-10-03 | Fremgangsmåde til lægemiddeludvikling |
Country Status (9)
Country | Link |
---|---|
US (2) | US8426345B2 (da) |
EP (1) | EP1934388B1 (da) |
JP (1) | JP5174672B2 (da) |
CN (2) | CN102796147A (da) |
CA (1) | CA2619457C (da) |
DK (1) | DK1934388T3 (da) |
ES (1) | ES2400509T3 (da) |
PL (1) | PL1934388T3 (da) |
WO (1) | WO2007038829A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796147A (zh) | 2005-10-04 | 2012-11-28 | 阿尔卡米亚有限公司 | 化合物库 |
JOP20190215A1 (ar) * | 2017-03-24 | 2019-09-19 | Ionis Pharmaceuticals Inc | مُعدّلات التعبير الوراثي عن pcsk9 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018971A1 (en) | 1994-01-11 | 1995-07-13 | Affymax Technologies N.V. | Methods for the solid phase synthesis of glycoconjugates |
AU2341197A (en) * | 1996-03-21 | 1997-10-10 | Intercardia, Inc. | Solid phase lipoglycopeptide library, compositions and methods |
DE69835679T2 (de) * | 1997-08-28 | 2007-08-23 | Biomira, Inc., Edmonton | Zufälligverteilt erzeugte kombinatorische peptidbibliotheken |
US6344330B1 (en) * | 1998-03-27 | 2002-02-05 | The Regents Of The University Of California | Pharmacophore recombination for the identification of small molecule drug lead compounds |
CN1314913A (zh) * | 1998-06-10 | 2001-09-26 | 格里科设计公司 | 有针对性的组合化合物库及其进行筛选所用的高效测定方法 |
US7338932B2 (en) * | 2000-05-11 | 2008-03-04 | Glycozym Aps | Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments |
AUPS143402A0 (en) | 2002-03-28 | 2002-05-09 | Alchemia Pty Ltd | Anomeric derivatives of monosaccharides |
AU2002950657A0 (en) * | 2002-08-08 | 2002-09-12 | Alchemia Limited | Derivatives of monosaccharides for drug discovery |
AU2002951247A0 (en) * | 2002-09-06 | 2002-09-19 | Alchemia Limited | Compounds that interact with kinases |
AU2002951995A0 (en) * | 2002-10-11 | 2002-10-31 | Alchemia Limited | Classes of compounds that interact with gpcrs |
US20080280837A1 (en) * | 2004-04-08 | 2008-11-13 | Judy Halliday | Biologically Active Compounds with Anti-Angiogenic Properties |
CN102796147A (zh) | 2005-10-04 | 2012-11-28 | 阿尔卡米亚有限公司 | 化合物库 |
-
2006
- 2006-10-03 CN CN2012102957795A patent/CN102796147A/zh active Pending
- 2006-10-03 EP EP06790302A patent/EP1934388B1/en active Active
- 2006-10-03 DK DK06790302.1T patent/DK1934388T3/da active
- 2006-10-03 CA CA2619457A patent/CA2619457C/en active Active
- 2006-10-03 PL PL06790302T patent/PL1934388T3/pl unknown
- 2006-10-03 US US12/063,920 patent/US8426345B2/en active Active
- 2006-10-03 ES ES06790302T patent/ES2400509T3/es active Active
- 2006-10-03 JP JP2008533820A patent/JP5174672B2/ja active Active
- 2006-10-03 CN CN2006800367207A patent/CN101278079B/zh active Active
- 2006-10-03 WO PCT/AU2006/001431 patent/WO2007038829A1/en active Application Filing
-
2013
- 2013-02-20 US US13/772,222 patent/US9709571B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN101278079B (zh) | 2012-09-19 |
EP1934388A4 (en) | 2010-07-21 |
CA2619457C (en) | 2016-09-06 |
ES2400509T3 (es) | 2013-04-10 |
US20090163373A1 (en) | 2009-06-25 |
US20130172210A1 (en) | 2013-07-04 |
CN102796147A (zh) | 2012-11-28 |
EP1934388B1 (en) | 2012-12-05 |
CA2619457A1 (en) | 2007-04-12 |
JP5174672B2 (ja) | 2013-04-03 |
CN101278079A (zh) | 2008-10-01 |
WO2007038829A8 (en) | 2008-03-27 |
EP1934388A1 (en) | 2008-06-25 |
US9709571B2 (en) | 2017-07-18 |
US8426345B2 (en) | 2013-04-23 |
JP2009510130A (ja) | 2009-03-12 |
WO2007038829A1 (en) | 2007-04-12 |
PL1934388T3 (pl) | 2013-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1879623T3 (da) | Genterapi til rygmarvssygdomme | |
DK2041139T3 (da) | Farmaceutiske forbindelser | |
DK1962932T3 (da) | Indretning til medikamentdosering | |
DE602006007875D1 (de) | Kapseln | |
DE602005006185D1 (de) | Entwicklungsverfahren | |
DK3424932T3 (da) | Bronophthalider til terapeutisk anvendelse | |
DK1957073T3 (da) | Lægemiddel | |
DK2047098T3 (da) | Kalibreringsfremgangsmåde | |
DK1860941T3 (da) | Biphenyl-N-(4-pyridyl)methylsufonamider | |
DK1880781T3 (da) | Fremgangsmåde til kasseløs formning | |
DK1910325T3 (da) | Nye farmaceutisk forbindelser | |
DE602007013849D1 (de) | Mikroreaktor | |
DE602006012689D1 (de) | Überprüfungsverfahren | |
DK2020845T3 (da) | Fremgangsmåde til høstning | |
DK1943240T3 (da) | Kemisk fremgangsmåde | |
DE602006001668D1 (de) | Fehlerüberprüfungsverfahren | |
DK1955066T3 (da) | Membran-assay-fremgangsmåde | |
DK1934388T3 (da) | Fremgangsmåde til lægemiddeludvikling | |
DE602006018034D1 (de) | Enzymherstellungsverfahren | |
JP2008525507A5 (ja) | 置換された4−アルコキシカルボニル−3−アミノチオフェン類の製造方法 | |
DE602006003519D1 (de) | Aufzeichnungsverfahren | |
NO20054652D0 (no) | Fremgangsmate for fremstilling | |
FI20041315A0 (fi) | Prosessi | |
NO20053978D0 (no) | Process. | |
SE0401623D0 (sv) | New process |